{"transactions":[{"id":816321,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-03T21:43:32.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":22165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 1, 2027, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":22165,"derivative":{"exercise_price":1.64,"expiration_date":"2036-04-01","underlying":"Ordinary Shares","underlying_shares":22165},"source":{"system":"sec-edgar","filing":"0001193125-26-142402","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000119312526142402/ownership.xml","form_type":"4"}},{"id":929977,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-27T21:10:13.000Z","date":"2026-01-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":3261,"price":6.67,"value":21750.87,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025."}],"balance_after":64115,"source":{"system":"sec-edgar","filing":"0001213900-26-008221","document":"marketforms-71931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000121390026008221/marketforms-71931.xml","form_type":"4"}},{"id":933395,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-22T21:30:24.000Z","date":"2026-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":3063,"price":5.6,"value":17152.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2024."}],"balance_after":67376,"source":{"system":"sec-edgar","filing":"0001213900-26-006709","document":"marketforms-71771.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000121390026006709/marketforms-71771.xml","form_type":"4"}},{"id":934209,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-21T21:37:07.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":175000,"derivative":{"exercise_price":5.01,"expiration_date":"2036-01-15","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001213900-26-006230","document":"marketforms-71896.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000121390026006230/marketforms-71896.xml","form_type":"4"}},{"id":934208,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-21T21:37:07.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":70439,"source":{"system":"sec-edgar","filing":"0001213900-26-006230","document":"marketforms-71896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000121390026006230/marketforms-71896.xml","form_type":"4"}},{"id":1167090,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-04-23T12:58:04.000Z","date":"2025-04-21","kind":"grant","planned":false,"acquired":true,"shares":23793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 21, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":23793,"derivative":{"exercise_price":1.31,"expiration_date":"2035-04-21","underlying":"Ordinary Shares","underlying_shares":23793},"source":{"system":"sec-edgar","filing":"0000950170-25-056985","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000095017025056985/ownership.xml","form_type":"4"}},{"id":1293043,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-28T21:05:12.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 24, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":140000,"derivative":{"exercise_price":4.53,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001213900-25-007530","document":"marketforms-67928.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000121390025007530/marketforms-67928.xml","form_type":"4"}},{"id":1293042,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-28T21:05:12.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 24, 2025."}],"balance_after":45500,"source":{"system":"sec-edgar","filing":"0001213900-25-007530","document":"marketforms-67928.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000121390025007530/marketforms-67928.xml","form_type":"4"}},{"id":1296366,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-23T21:05:14.000Z","date":"2025-01-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":3061,"price":4.76,"value":14570.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2024."}],"balance_after":18939,"source":{"system":"sec-edgar","filing":"0001213900-25-005966","document":"marketforms-67896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000121390025005966/marketforms-67896.xml","form_type":"4"}},{"id":1673011,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-23T21:05:22.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":131000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":131000,"derivative":{"exercise_price":1.91,"expiration_date":"2034-01-18","underlying":"Common Stock","underlying_shares":131000},"source":{"system":"sec-edgar","filing":"0001213900-24-005723","document":"marketforms-64339.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000121390024005723/marketforms-64339.xml","form_type":"4"}},{"id":1673010,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-23T21:05:22.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024."}],"balance_after":22000,"source":{"system":"sec-edgar","filing":"0001213900-24-005723","document":"marketforms-64339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000121390024005723/marketforms-64339.xml","form_type":"4"}},{"id":2042151,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-30T21:52:23.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares shall vest on January 30, 2024 and the remainder of the shares will vest in a series of thirty-six successive equal monthly installments measured from January 30, 2024, subject to the Reporting Person's Continuous Service (as defined in the Company's 2020 Inducement Plan) with the Issuer through each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":3.14,"expiration_date":"2033-01-29","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-23-006044","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000121390023006044/ownership.xml","form_type":"4"}},{"id":2076756,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & President"}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2022-12-23T15:04:15.000Z","date":"2022-12-21","kind":"tax_withholding","acquired":false,"shares":27928,"price":1.76,"value":49153.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer for tax purposes upon vesting of Restricted Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 50,139 shares of stock held directly and 285,036 shares of Restricted Stock that vest as follows: 19,517 shares to vest quarterly, commencing March 21, 2023, through December 21, 2023; and 25,871 shares to vest quarterly, commencing March 21, 2024 through December 21, 2025."}],"balance_after":335175,"source":{"system":"sec-edgar","filing":"0001209191-22-062551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000120919122062551/doc4.xml","form_type":"4"}},{"id":2413996,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & President"}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2022-02-03T13:50:04.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":363103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock that vests as follows: 78,067 to vest on December 21, 2022; 19,517 shares to vest quarterly, commencing March 21, 2023, through December 21, 2023; and 25,871 shares to vest quarterly, commencing March 21, 2024 through December 21, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of shares of Restricted Stock that vest as follows: 78,067 to vest on December 21, 2022; 19,517 shares to vest quarterly, commencing March 21, 2023, through December 21, 2023; and 25,871 shares to vest quarterly, commencing March 21, 2024 through December 21, 2025."}],"balance_after":363103,"source":{"system":"sec-edgar","filing":"0001209191-22-006650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000120919122006650/doc4.xml","form_type":"4"}},{"id":2564033,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-09-20T18:51:20.000Z","date":"2021-09-17","kind":"grant","acquired":true,"shares":105602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest as follows: 25% shall vest on September 17, 2022 and additional equity with respect to 2.0833% of the options shall vest on each monthly anniversary thereafter, such that all equity shall vest by September 17, 2025."}],"balance_after":105602,"derivative":{"exercise_price":36.32,"expiration_date":"2031-09-16","underlying":"Class B Common Stock","underlying_shares":105602},"source":{"system":"sec-edgar","filing":"0001209191-21-056826","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000120919121056826/doc4.xml","form_type":"4"}},{"id":3229456,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2020-03-04T16:15:02.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":82214,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"3yr 33% On Vest beginning on 02-Mar-2020"}],"balance_after":82214,"derivative":{"exercise_price":4.77,"expiration_date":"2030-03-02","underlying":"Common Stock","underlying_shares":82214},"source":{"system":"sec-edgar","filing":"0001562180-20-002131","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000156218020002131/primarydocument.xml","form_type":"4"}},{"id":3616096,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2019-03-05T15:53:06.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":90750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"3yr 33% On Vest beginning on 01-Mar-2019"}],"balance_after":90750,"derivative":{"exercise_price":4.52,"expiration_date":"2029-03-01","underlying":"Common Stock","underlying_shares":90750},"source":{"system":"sec-edgar","filing":"0001562180-19-001668","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000156218019001668/primarydocument.xml","form_type":"4"}},{"id":4022221,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-03-02T13:09:36.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":94875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"3yr 33% On Vest beginning on 01-Mar-2018"}],"balance_after":94875,"derivative":{"exercise_price":6.62,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":94875},"source":{"system":"sec-edgar","filing":"0001562180-18-001354","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000156218018001354/primarydocument.xml","form_type":"4"}},{"id":4398929,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2017-03-07T11:35:14.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"3yr 33% On Vest beginning on 01-Mar-2017"}],"balance_after":82500,"derivative":{"exercise_price":11.32,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001562180-17-001135","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000156218017001135/primarydocument.xml","form_type":"4"}}]}